These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29997212)

  • 1. Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.
    Walton RW; Brown MC; Sacco MT; Gromeier M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.
    Holl EK; Brown MC; Boczkowski D; McNamara MA; George DJ; Bigner DD; Gromeier M; Nair SK
    Oncotarget; 2016 Nov; 7(48):79828-79841. PubMed ID: 27806313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.
    Brown MC; Gromeier M
    Curr Opin Virol; 2015 Aug; 13():81-5. PubMed ID: 26083317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Poliovirus for Cancer Immunotherapy.
    Gromeier M; Nair SK
    Annu Rev Med; 2018 Jan; 69():289-299. PubMed ID: 29414253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKR Binds Enterovirus IRESs, Displaces Host Translation Factors, and Impairs Viral Translation to Enable Innate Antiviral Signaling.
    Dobrikov MI; Dobrikova EY; McKay ZP; Kastan JP; Brown MC; Gromeier M
    mBio; 2022 Jun; 13(3):e0085422. PubMed ID: 35652592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic polio virotherapy of cancer.
    Brown MC; Dobrikova EY; Dobrikov MI; Walton RW; Gemberling SL; Nair SK; Desjardins A; Sampson JH; Friedman HS; Friedman AH; Tyler DS; Bigner DD; Gromeier M
    Cancer; 2014 Nov; 120(21):3277-86. PubMed ID: 24939611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
    Brown MC; Holl EK; Boczkowski D; Dobrikova E; Mosaheb M; Chandramohan V; Bigner DD; Gromeier M; Nair SK
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Glioblastoma Treated with Recombinant Poliovirus.
    Desjardins A; Gromeier M; Herndon JE; Beaubier N; Bolognesi DP; Friedman AH; Friedman HS; McSherry F; Muscat AM; Nair S; Peters KB; Randazzo D; Sampson JH; Vlahovic G; Harrison WT; McLendon RE; Ashley D; Bigner DD
    N Engl J Med; 2018 Jul; 379(2):150-161. PubMed ID: 29943666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.
    Beasley GM; Nair SK; Farrow NE; Landa K; Selim MA; Wiggs CA; Jung SH; Bigner DD; True Kelly A; Gromeier M; Salama AK
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33875611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
    Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis.
    Brown MC; Dobrikov MI; Gromeier M
    J Virol; 2014 Nov; 88(22):13149-60. PubMed ID: 25187540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway.
    Li LF; Yu J; Zhang Y; Yang Q; Li Y; Zhang L; Wang J; Li S; Luo Y; Sun Y; Qiu HJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
    Goetz C; Gromeier M
    Cytokine Growth Factor Rev; 2010; 21(2-3):197-203. PubMed ID: 20299272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.
    Brown MC; Gromeier M
    Discov Med; 2015 May; 19(106):359-65. PubMed ID: 26105699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Practical Consideration of Poliovirus as an Oncolytic Virotherapy.
    Denniston E; Crewdson H; Rucinsky N; Stegman A; Remenar D; Moio K; Clark B; Higginbotham A; Keffer R; Brammer S; Horzempa J
    Am J Virol; 2016; 5(1):1-7. PubMed ID: 28203321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS.
    Yang Y; Brown MC; Zhang G; Stevenson K; Mohme M; Kornahrens R; Bigner DD; Ashley DM; López GY; Gromeier M
    Neuro Oncol; 2023 Sep; 25(9):1631-1643. PubMed ID: 36864784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity.
    Mosaheb MM; Dobrikova EY; Brown MC; Yang Y; Cable J; Okada H; Nair SK; Bigner DD; Ashley DM; Gromeier M
    Nat Commun; 2020 Jan; 11(1):524. PubMed ID: 31988324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-type-specific innate immune response to oncolytic Newcastle disease virus.
    Biswas M; Kumar SR; Allen A; Yong W; Nimmanapalli R; Samal SK; Elankumaran S
    Viral Immunol; 2012 Aug; 25(4):268-76. PubMed ID: 22808996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.